Product NDC: | 64067-216 |
Proprietary Name: | UVADEX |
Non Proprietary Name: | Methoxsalen |
Active Ingredient(s): | 20 ug/mL & nbsp; Methoxsalen |
Administration Route(s): | EXTRACORPOREAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64067-216 |
Labeler Name: | Therakos, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020969 |
Marketing Category: | NDA |
Start Marketing Date: | 19990225 |
Package NDC: | 64067-216-01 |
Package Description: | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS |
NDC Code | 64067-216-01 |
Proprietary Name | UVADEX |
Package Description | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS |
Product NDC | 64067-216 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methoxsalen |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EXTRACORPOREAL |
Start Marketing Date | 19990225 |
Marketing Category Name | NDA |
Labeler Name | Therakos, Inc. |
Substance Name | METHOXSALEN |
Strength Number | 20 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient] |